Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency

Asian Pacific Journal of Tropical Disease

Volumn 3, Issue 2, 2013, Pages 93-102

  Joseph, Baby ^a   Jini, D ^a  

^a MALANKARA CATHOLIC COLLEGE   (India)

Author keywords

Bioactive compounds; Bitter melon; Diabetes; Glucose metabolism; Hypoglycaemic agents; Insulin; Medicinal plant; Momordica charantia

Indexed keywords

ALKALOID; ASPARTIC ACID; CHARANTIN; CHLORPROPAMIDE; CRYPTOXANTHIN; CYCLOARTENOL; DIOSGENIN; ERYTHRODIOL; GALACTURONIC ACID; GENTISIC ACID; GLIBENCLAMIDE; GLUCOBETIC; GOURDIN; INORGANIC COMPOUND; LANOSTEROL; LIPID; MOMORDICA CHARANTIA EXTRACT; MOMORDIN; OXALIC ACID; P INSULIN; PHENOL DERIVATIVE; PLANT MEDICINAL PRODUCT; PROTEID; SERINE; SEROTONIN; STEROID; TOLBUTAMIDE; TRITERPENE; UNCLASSIFIED DRUG; UNINDEXED DRUG; URACIL; VICINE; ZEATIN;

ANTHELMINTIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTIDIABETIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; BREAST CANCER; CATARACT; CELL REGENERATION; DIABETES MELLITUS; DIET SUPPLEMENTATION; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG POTENCY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; INDUCED ABORTION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MALARIA; MENSTRUATION DISORDER; NEUROPROTECTION; NONHUMAN; PANCREAS ISLET BETA CELL; PHYTOCHEMISTRY; PLANT STRUCTURES; PRIORITY JOURNAL;

EID: 84875084039     PISSN: 22221808     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2222-1808(13)60052-3     Document Type: Article

References (117)

1. Joseph B, Jini D Insight into the hypoglycaemic effect of traditional Indian herbs used in the treatment of diabetes. Res J Med Plant 2011, 5(4):352-376.
2. Shaw JE, Sicree RA, Zimmet PZ Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87:4-14.
3. Patel DK, Prasad SK, Kumar R, Hemelatha S An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pac J Trop Biomed 2012, 2:320-330.
4. Ogbonnia SO, Odimegu JI, Enwuru VN Evaluation of hypoglycemic and hypolipidemic effects of ethanolic extracts of Treculia africana Decne and Bryopyllum pinnatum Lam. and their mixture on streptozotocin (STZ)- induced diabetic rats. Afr J Biotech 2008, 7(15):2535-2539.
5. Sharma AK, Aggarwal A, Singhal VK Treatment of diabetes mellitus with indian herbal Drugs. IJARPB 2012, 1(2):145-153.
6. Raman BV, Krishna NV, Rao NB, Saradhi PM, Rao BMV Plants with antidiabetic activities and their medicinal values. Int Res J Pharm 2012, 3(3):11-15.
7. Joseph B, Raj SJ Phytopharmacological properties of Ficus racemosa Linn - An overview. Int J Pharm Sci Rev Res 2010, 3(2):134-138.
8. Joseph B, Jini D, Ajisha SU Phytochemical characterization of herbal drug formulation for arthritis. Res J Phytochem 2012, 6(2):54-60.
9. Singh U, Singh S, Kochhar A Therapeutic potential of antidiabetic neutraceuticals. Phytopharmacol 2012, 2(1):144-169.
10. Zohary D, Hopf M Domestication of plants in the old world 2000, 122. Oxford University Press, Oxford.
11. Cefalu WT, Ye J, Wang ZQ Efficacy of dietary supplementation with botanicals on carbohydrate metabolism in humans. Endocr Metab Immune Disord Drug Targets 2008, 8:78-81.
12. Cousens G There is a cure for diabetes: the tree of life 21 day program 2008, 191-192. North Atlantic Books, California.
13. Joseph B, Raj SJ Pharmacognostic and phytochemical properties of Aleo vera Linn - An overview. Int J Pharm Sci Rev Res 2010, 4(2):106-110.
14. Joseph B, Jini D A medicinal potency of Capparis decidua - A harsh terrain plant. Res J Phytochem 2011, 5(1):1-13.
15. Ayodhya S, Kusum S, Anjali S Hypoglycaemic activity of different extracts of various herbal plants. IJRAP 2010, 1(1):212-224.
16. Malviya N, Jain S, Malviya S Anti-diabetic potential of medicinal plants. Acta Pol Pharm 2010, 67(2):113-118.
17. Patel P, Harde P, Pillai J, Darji N, Patel B Antidiabetic herbal drugs a review. Pharmacophore 2012, 3(1):18-29.
18. Kavishankar GB, Lakshmidevi N, Murthy SM, Prakash HS, Niranjana SR Diabetes and medicinal plants-A review. Int J Pharm Biomed Sci 2011, 2(3):65-80.
19. Hui H, Tang G, Liang VW, Go VLW Hypoglycemic herbs and their action mechanisms. Chin Med 2009, 4:11-14.
20. Abascal K, Yarnell E Using bitter melon to treat diabetes. J Altern Complement Med 2005, 1:179-184.
21. Lee SY, Eom SH, Kim YK, Park NI, Park SU Cucurbitane-type triterpenoids in Momordica charantia Linn. J Med Plants Res 2009, 3(13):1264-1269.
22. Bakare RI, Magbagbeola OA, Akinwande AI, Okunowo OW Nutritional and chemical evaluation of Momordica charantia. J Med Plant Res 2010, 4(21):2189-2193.
23. Snee LS, Nerurkar VR, Dooley DA, Efird JT, Shovic AC, Nerurkar PV Strategies to improve palatability and increase consumption intentions for Momordica charantia (bitter melon): A vegetable commonly used for diabetes management. Nutr J 2011, 10:78.
24. Saeed MK, Shahzadi I, Ahmad I, Ahmad R, Shahzad K, Ashraf M, et al. Nutritional analysis and antioxidant activity of bitter gourd (Momordica charantia) from Pakistan. Pharmacologyonline 2010, 1:252-260.
25. Budrat P, Shotipruk A Extraction of phenolic compounds from fruits of bitter melon (Momordica charantia) with subcritical water extraction and antioxidant activities of these extracts. Chiang Mai J Sci 2008, 35(1):123-130.
26. Chang CI, Chen CR, Liao YW, Cheng HL, Chen YC, Chou CH Cucurbitane-type triterpenoids from Momordica charantia. J Nat Prod 2006, 71:1327-1330.
27. Tan MJ, Ye JM, Turner N, Hohnen-Behrens C, Ke CQ, Tang CP, et al. Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway. Chem Biol 2008, 15:263-273.
28. Liu J, Chen J, Wang C, Qui M New cucurbitane triterpenoids and steroidal glycoside from Momordica charantia. Molecules 2009, 14:4804-4813.
29. Kumar DS, Sharathnath VK, Yogeswaran P, Harani A, Sudhakar K, Sudha P, et al. A medicinal potency of Momordica charantia. Int J Pharm Sci Rev Res 2010, 1(2):95-99.
30. Islam S, Jalaluddin M, Hettiarachchy NS Bio-active compounds of bitter melon genotypes (Momordica Charantia L.) in relation to their physiological functions. Funct Foods Health Dis 2011, 1(2):61-74.
31. Hazarika R, Parida P, Neog B, Yadav RNS Binding energy calculation of GSK-3 protein of human against some anti-diabetic compounds of Momordica charantia linn (Bitter melon). Bioinformation 2012, 8(6):251-254.
32. Wehash FE, Abpo-Ghanema II, Saleh RM Some physiological effects of Momordica charantia and Trigonella foenum-graecum extracts in diabetic rats as compared with cidophage®. World Academy of Science, Engineering and Technology 2012, 64:1206-1214.
33. Fuangchana A, Sonthisombata P, Seubnukarnb T, Chanouanc R, Chotchaisuwatd P, Sirigulsatiene V, et al. Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients. J Ethnopharmacol 2011, 134:422-428.
34. Keller AC, Ma J, Kavalier A, He K, Brillantes AM, Kennelly EJ Saponins from the traditional medicinal plant Momordica charantia stimulate insulin secretion in vitro. Phytomedicine 2011, 19:32-37.
35. Krawinkel MB, Keding GB Bitter gourd (Momordica charantia): a dietary approach to hyperglycemia. Nutr Rev 2006, 64:331-337.
36. Patel S, Patel T, Parmar K, Bhatt Y, Patel Y, Patel NMD Isolation, characterization and antimicrobial activity of charantin from Momordica charantia linn. Fruit. Int J Drug Deve Res 2010, 2(3):629-634.
37. Pitiphanpong J, Chitprasert S, Goto M, Jiratchariyakul W, Sasaki M, Shotipruk A New approach for extraction of charantin from Momordica charantia with pressurized liquid extraction. Sep Purif Technol 2007, 52:416-422.
38. Chen JC, Liu WQ, Lu L, Qiu MH, Zheng YT, Yang LM, et al. Kuguacins F-S, cucurbitane triterpenoids from Momordica charantia. Phytochem 2009, 70:133-140.
39. Thomas CT, Reddy PY, Devanna N Impact of cooking on charantin estimated from bitter melon fruits using high performance thin layer chromatography. Int Res J Pharm 2012, 3(6):149-154.
40. Harinantenaina L, Tanaka M, Takaoaka S, Oda M, Mogami O, Uchida M, et al. Momordica charantia constituents and antidiabetic screening of the isolated major compounds. Chem Pharm Bull 2006, 54:1017-1021.
41. Hellolife. Plypeptide-P (plant insulin)- A natural treatment for diabetes. The smart living network. [Online] [Accessed on 2nd August 2008]. http://www.smartlivingnetwork.com/diabetes/b/polypeptide-p-plant-insulin-a-natural-treatment-for-diabetes.
42. Tayyab F, Lal SS, Mishra M, Kumar U A review: Medicinal plants and its impact on diabetes. World J Pharm Res 2012, 1(4):1019-1046.
43. Paul A, Raychaudhuri SS Medicinal uses and molecular identification of two Momordica charantia varieties - a review. E J Bio 2010, 6(2):43-51.
44. Wang Bl, Zhang W, Zhao J, Wang F, Fan L, Hu Z Gene cloning and expression of a novel hypoglycaemic peptide from Momordica Charantia. J Sci Food Agric 2011, 91:2443-2448.
45. Haixia Z, Xiaozuo Z, Yawei W, Mancanq L, Zhide H Analysis of vicine in bitter melon samples by polyglycol-C8 solid phase with high performance liquid chromatography. Chin J Anal Chem 2004, 3:408. 108.
46. Ham C, Wang J Optimization of conditions for charantin extraction in PEG/Salt aqueous two-phase systems using response surface methodology. Open Compl Med J 2009, 1:46-50.
47. Basch WE, Gabardi S, Ulbricht C Bitter melon (Momordica charantia): A review of efficacy and safety. Am J Health Syst Pharm 2003, 60:356-359.
48. John JK, Simon PW, Staub JE Bitter gourd: Botany, horticulture, breeding. Horticulture Rev 2010, 37:101-141.
49. Yibchok-Anun S, Adisakwattana S, Yao CY, Sangvanich P, Roengsumran S, Hsu WH Slow acting protein extract from fruit pulp of Momordica charantia with insulin secretagogue and insulinomimetic activities. Biol Pharm Bull 2006, 29:1126-1131.
50. Grover JK, Yadav SP Pharmacological actions and potential uses of Momordica charantia: a review. J Ethnopharmacol 2004, 93:123-132.
51. Balasubramanian G, Sarathi M, Kumar SR, Hameed ASS Screening the antiviral activity of Indian medicinal plants against white spot syndrome virus in shrimp. Aquaculture 2007, 263:15-19.
52. Bot YS Screening for the anti HIV properties of the fruit pulp extract of M. balsamina [MMLS Dissertation] 2004, Ambrose Alli University, Ekpoma.
53. Haque EM, Alam BM, Hossain SM The efficacy of cucurbitane type triterpenoids, glycosides and phenolic compounds isolated from Momordica charantia: a review. IJPSR 2011, 2(5):1135-1146.
54. Ray RB, Raychoudhuri A, Steele R, Nerurkar P Bitter melon (Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis. Cancer Res 2010, 70(5):1925-1931.
55. Saeed S, Tariq P Antibacterial activities of Mentha piperita, Pisum sativum and Momordica charantia. Pakistan J Botany 2005, 37:997-1001.
56. Patil SA, Patil SB Toxicological studies of Momordica charantia Linn seed extracts in male mice. Int J Morphol 2011, 29(4):1212-1218.
57. Jarald E, Joshi SB, Jain DCH Diabetes and herbal medicines. Iran J pharm Therap 2008, 7(1):97-106.
58. Chauhan A, Sharma PK, Srivastava P, Kumar N, Dudhe R Plants having potential anti-diabetic activity: A review. Der Pharmacia Lettre 2010, 2(3):369-387.
59. Singh LW Traditional medicinal plants of Manipur as anti-diabetics. J Med Plants Res 2011, 5(5):677-687.
60. Hasan I, Khatoon S Effect of Momordica charantia (bitter gourd) tablets in diabetes mellitus: Type 1 and Type 2. Prime Res Med (PROM) 2012, 2(2):72-74.
61. Leung L, Birtwhistle R, Kotecha J, Hannah S, Cuthbertson S Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review. Br J Nutr 2009, 102:1703-1708.
62. Taylor L Herbal secrets of the rainforest. Bitter melon Momordica charantia) 2002, 1-100. Sage Press, USA. 2nd ed. A. Texas (Ed.).
63. Garau C, Cummings E, Phoenix DA, Singh J Beneficial effects and mechanism of action of Momordica charantia in the treatment of diabetes mellitus: a mini review. Int J Diabetes Metab 2003, 11:46-55.
64. Bhushan MS, Rao CHV, Ojha SK, Vijayakumar M, Verma A An analytical review of plants for anti diabetic activity with their phytoconstituent and mechanism of action. IJPSR 2010, 1(1):29-46.
65. Kim K, Kim HY Bitter melon (Momordica charantia) extract suppresses cytokine induced activation of MAPK and NF-κB in pancreatic β-cells. Food Sci Biotechnol 2011, 20(2):531-535.
66. Gadang V, Gilbert W, Hettiararchchy N, Horax R, Katwa L, Devareddy L Dietary bitter melon seed increases peroxisome proliferator-activated receptor-γ? gene expression in adipose tissue, down-regulates the nuclear factor-κB expression, and alleviates the symptoms associated with metabolic syndrome. J Med Food 2011, 14:86-93.
67. Ragasa CY, Alimboyoguen AB, Shen CC, Del Fierro RS, Raga DD Hypoglycemic effects of tea extracts and sterols from Momordica charantia. J Nat Remedies 2011, 11:44-53.
68. Malik ZA, Singh M, Sharma PL Neuroprotective effect of Momordica charantia in global cerebral ischemia and reperfusion induced neuronal damage in diabetic mice. J Ethnopharmacol 2011, 133:729-734.
69. Hoang DM, Trung TN, Hien PTT, Ha DT, Van Luong H, Lee M, et al. Screening of protein tyrosine phosphatase 1B inhibitory activity from some Vietnamese medicinal plants. Nat Prod Sci 2010, 16:239-244.
70. Sǎrǎndan H, Botǎu D, Ianculov I, Radu F, Rada O, Morar D, et al. The hypoglicemic effect of Momordica charantia Linn in normal and alloxan induced diabetic rabbits. Scientific Papers: Animal Science and Biotechnologies 2010, 43(1):516-518.
71. Cummings E, Hundal HS, Wackerhage H, Hope M, Belle M, Adeghate E, et al. Momordica charantia fruit juice stimulates glucose and amino acid uptakes in L6 myotubes. Mol Cell Biochem 2004, 261:99-104.
72. Akhtar N, Khan BA, Majid A, Khan S, Mahmood T, Gulfishan, et al. Pharmaceutical and biopharmaceutical evaluation of extracts from different plant parts of indigenous origin for their hypoglycemic responses in rabbits. Acta Pol Pharm 2011, 68(6):919-925.
73. Uebanso T, Arai H, Taketani Y, Fukaya M, Yamamoto H, Mizuno A, et al. Extracts of Momordica charantia supress postprandial hyperglycemia in rats. J Nutr Sci Vitaminol (Tokyo) 2007, 53(6):482-486.
74. Jeong J, Lee S, Hue J, Lee K, Nam SY, Yun YW, et al. Effect of bittermelon (Momordica Charantia) on antidiabetic activity in C57BL/6J db/db mice. Korean J Vet Res 2008, 48(3):327-336.
75. Abdollah M, Zuki ABZ, Goh YM, Rezaeizadeh A, Noordin MM The effects of Momordica charantia on the liver in streptozotocin-induced diabetes in neonatal rats. Afr J Biotechnol 2010, 9(31):5004-5012.
76. Nerurkar PV, Lee YK, Nerurkar VR Momordica charantia (bitter melon) inhibits primary human adipocyte differentiation by modulating adipogenic genes. BMC Complement Altern Med 2010, 10:34.
77. Shibib BA, Khan LA, Rahman R Hypoglycaemic activity enzymes glucose-6-phosphatase and fructose-1,6-bisphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6-phosphate dehydrogenase. Biochem J 1993, 292:267-270.
78. Singh J, Cumming E, Manoharan G, Kalasz H, Adeghate E Medicinal chemistry of the anti-diabetic effects of Momordica Charantia: active constituents and modes of actions. Open Med Chem J 2011, 5:70-77.
79. Jeevathayaparan S, Tennekoon KH, Karunanayake EH A comparative study of the oral hypoglycaemic effect of Momordica charantia fruit juice and tolbutamine in streptozotocin induced graded severity diabetes in rat. Int J Diabetes 1995, 3:99-108.
80. Ahmed I, Cummings E, Sharma AK, Adeghate E, Singh J Beneficial effects and mechanism of action of Momordica charantia fruit juice in the treatment of streptozotocin-induced diabetes mellitus in rats. Mol Cell Biochem 2004, 261:63-70.
81. Singh N, Gupta M, Sirohi P, Varsha Effects of alcoholic extract of Momordica charantia (Linn.) whole fruit powder on the pancreatic islets of alloxan diabetic albino rats. J Environ Biol 2008, 29(1):101-106.
82. Parmar K, Patel S, Patel J, Patel B, Patel MB Effects of bittergourd (Momordica charantia) fruit juice on glucose tolerance and lipid profile in type-II diabetic rats. Int J Drug Dev Res 2011, 3(2):139-146.
83. Sattiel AL, Khan CR In insulin signalling and regulation of glucose and lipid metabolism. Nature 2001, 414:799-806.
84. Kumar PJ, Clark M Textbook of clinical medicine. Diabetes mellitus and other disorders of metabolism 2005, 1069-1121. Saunders, London.
85. Shetty AK, Kumar SG, Sambaiah K, Salimath PV Effect of bitter gourd (Momordica charantia) on glycaemic status in streptozotocin induced diabetic rats. Plant Foods Hum Nutr 2005, 60:109-112.
86. Hanhineva K, Torronen R, Bondia-Pons I, Pekkinen J, Kolehmainen M, Mykkanen H, et al. Impact of dietary polyphenols on carbohydrate metabolism. Int J Mol Sci 2010, 11:1365-1402.
87. Ismail WFE, Abo-Ghanema II, Saleh RM Some physiological effects of Momordica charantia and Trigonella foenum-graecum extracts in diabetic rats as compared with cidophage®. World Academy of Science, Engineering and Technology 2012, 64:1206-1214.
88. Mohammady I, Elattar S, Mohammed S, Ewais M An evaluation of anti-diabetic and anti-lipidemic properties of Momordica charantia (Bitter Melon) fruit extract in experimentally induced diabetes. Life Sci J 2012, 9(2):363-374.
89. Chen Q, Chan LL, Li ET Bitter melon (Momordica charantia) reduces adiposity, lowers serum insulin and normalizes glucose tolerance in rats fed a high fat diet. J Nutr 2003, 133:1088-1093.
90. Chen Q, Li ET Reduced adiposity in bitter melon (Momordica charanita) fed rats is associated with lower tissue triglyceride and higher plasma catecholamines. Br J Nutr 2005, 93:747-754.
91. Jayasooriya AP, Sakono M, Yukizaki C, Kawano M, Yamamoto K, Fukuda N Effects of Momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterol-free and cholesterol-enriched diets. J Ethnopharmacol 2000, 172:331-336.
92. Ojewole JA, Adewole SO, Olayiwola G Hypoglycaemic and hypotensive effects of Momordica charantia Linn. (Cucurbitaceae) whole-plant aqueous extract in rats. Cardiovasc J Afr 2006, 17:227-232.
93. Virdi J, Sivakami S, Shahani S, Suthar AC, Banavalikar MM, Biyani MK Antihyperglycemic effects of three extracts from Momordica charantia. J Ethnopharmacol 2003, 88:107-111.
94. Miura T, Itoh C, Iwamoto N, Kato M, Kawai M, Park SR, et al. Hypoglycemic activity of the fruit of the Momordica charantia in type 2 diabetic mice. J Nutr Sci Vitaminol 2001, 47:340-344.
95. Zheng D, MacLean PS, Pohnert SC, Knight JB, Olson AL, Winder WW, et al. Regulation of muscle GLUT-4 transcription by AMP-activated protein kinase. J Appl Physiol 2001, 91:1073-1083.
96. McCarty MF Does bitter melon contain an activator of AMP-activated kinase?. Medical Hypotheses 2004, 63:340-343.
97. Cheng HL, Huang HK, Chang CI, Tsai CP, Chou CH A cell-based screening identifies compounds from the stem of Momordica charantia that overcome insulin resistance and activate AMP-activated protein kinase. J Agric Food Chem 2008, 27:6835-6843.
98. Huang HL, Hong YW, Wong YH, Chen YN, Chyuan JH, Huang CJ, et al. Bitter melon (Momordica charantia L.) inhibits adipocyte hypertrophy and down regulates lipogenic gene expression in adipose tissue of diet-induced obese rats. Br J Nutr 2008, 99:230-239.
99. Shih CC, Lin CH, Lin WL Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet. Diabetes Res Clin Pract 2008, 81:134-143.
100. Singh N, Gupta M Regeneration of β? cells in islets of langerhans of pancreas of alloxan diabetic rats by acetone extract of Momordica charantia (Linn.) (bitter gourd) fruits. Indian J Exp Biol 2007, 45:1055-1062.
101. Rahman IU, Basir M, Salman M, Idrees M, Khan MI Bitter melon (Momordica charantia) reduces serum sialic acid in type 2 diabetics: Evidence to delay the process of therosclerosis. Chin Med 2011, 2:125-129.
102. Michael B, Krawinkel MD, Keding GB Bitter gourd (Momordica charantia): A dietary approach to hyperglycemia. Nutr Rev 2006, 64(7):331-337.
103. Diabetes UK. Statement on Karela Capsules. London: Diabetes UK. [Online] [Accessed on 13th June 2006]. http://www.diabetes.org.uk/infocentre/inform/karela.htm.
104. Lakholia AN The use of bitter gourd in diabetes mellitus. Antiseptic 1956, 53:608-610.
105. Tsi C, Chen EC, Tsay H, Huang C Wild bitter gourd improves metabolic syndrome: A preliminary dietary supplementation trial. Nutr J 2012, 11:4.
106. Dans AM, Villarruz MV, Jimeno CA, Anthony M, Javelosab U, Chuaa J, et al. The effect of Momordica charantia capsule preparation on glycemic control in type 2 diabetes mellitus needs further studies. J Clin Epidemiol 2007, 60:554-559.
107. Tongia A, Tongia SK, Dave M Phytochemical determination and extraction of Momordica charantia fruit and its hypoglycemic potentiation of oral hypoglycemic drugs in diabetes mellitus (NIDDM). Indian J Physiol Pharmacol 2004, 48:241-244.
108. John AJ, Cherian R, Subhash HS, Cherian AM Evaluation of the efficacy of bitter gourd (Momordica charantia) as an oral hypoglycemic agent - a randomized controlled clinical trial. Indian J Physiol Pharm 2003, 47:363-365.
109. Ahmad N, Hassan MR, Halder H, Bennoor KS Effect of Momordica charantia (Karolla) extracts on fasting and postprandial serum glucose in NIDDM patients. Bangladesh Med Res Council Bull 1999, 25:11-13.
110. Rivastava Y, Venkatakrishna-Bhatt H, Verma Y Antidiabetic and adaptogenic properties of Momordica charantia extract: an experimental and clinical evaluation. Phytother Res 1993, 7:285-289.
111. Grover JK, Gupta SR Hypoglycemic activity of seeds of Momordica charantia. Eur J Pharmacol 1990, 183:1026-1027.
112. Welihinda J, Arvidson G, Gyfle E, Hellman B, Karlsson E The insulin-releasing activity of the tropical plant Momordica charantia. Acta Biol Med Germ 1982, 41:1229-1240.
113. Akhtar MS Trial of Momordica charantia Linn (Karela) powder in patients with maturity-onset diabetes. J Pakistan Med Assoc 1982, 32:106-107.
114. Leatherdale BA, Panesar RK, Singh G, Atkins TW, Bailey CJ, Bignell AH Improvement in glucose tolerance due to Momordica charantia (karela). Br Med J 1981, 282:1823-1824.
115. Khanna P, Jain SC, Panagariya A, Dixt VP Hypoglycaemic activity of polypeptide-p from a plant source. J Nat Prod 1981, 44:648-655.
116. Baldwa VS, Bhandari CM, Pangaria A, Goyal RK Clinical trials in patients with diabetes mellitus of an insulin-like compound obtained from plant source. Ups J Med Sci 1977, 82:39-41.
117. Patel JC, Dhirawani MK, Doshi JC 'Karella' in the treatment of diabetes mellitus. Indian J Med Sci 1968, 22:30-32.